CHRNA9 antibody
Quick Overview for CHRNA9 antibody (ABIN7112723)
Target
See all CHRNA9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purification
- Immunogen affinity purified
-
Purity
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- cholinergic receptor, nicotinic, alpha 9
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:500-1:2000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- -20°C for 12 months (Avoid repeated freeze / thaw cycles.)
-
Expiry Date
- 12 months
-
-
- CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
-
Alternative Name
- CHRNA9
-
Background
- Synonyms:NACHRA9 Background:Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane(PubMed:11752216, PubMed:25282151). The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane(PubMed:11752216, PubMed:25282151). In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion(PubMed:11021840).
-
Molecular Weight
- 50-55 kDa
-
Gene ID
- 55584
-
UniProt
- Q9UGM1
-
Pathways
- Sensory Perception of Sound
Target
-